{"url_path":"/sec/kytx/8-k/2026-07-09/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-09","source_url":"https://www.sec.gov/Archives/edgar/data/1994702/0001193125-26-298979-index.html","accession_number":"0001193125-26-298979","cik":"0001994702","ticker":"KYTX","issuer_name":"Kyverna Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1994702/0001193125-26-298979-index.html","primary_entity_key":"0001994702","primary_entity_name":"Kyverna Therapeutics, Inc."},"word_count":70,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\nd) Exhibits\n\nExhibit\n\nNumber\n\nDescription\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nKYVERNA THERAPEUTICS, INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nJuly 9, 2026\n\nBy:\n\n/s/ Gregory Martini\n\n \n\n \n\n \n\nGregory Martini\nChief Financial Officer"}